Karolinska Development AB announced that OssDsign AB has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands. Details from the OssDsign announcement follow: OssDsign's lead products - OSSDSIGN Cranial and OSSDSIGN Facial - are already on sale in Germany, the UK and the Nordic region, as well as selected non-European markets including Singapore and Israel. The Company is preparing for its first product launch in the US, which is anticipated during the first quarter of 2017, and is also undertaking regulatory and commercial activities in Japan. OssDsign commercial strategy is focused on building sales of its innovative products through a combination of internal sales organisation and distribution partnerships.